Clinical Trial Update: A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the combination of sitagliptin and atorvastatin in inadequately controlled Type 2 Diabetes Mellitus was terminated, with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Januvia (sitagliptin)
• Lipitor (atorvastatin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: TERMINATED | Results posted: 2016-10-05